Atlas Trials

Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid Tumours

Clinical trial NCT04236414 · COMPLETED

Trial details

NCT number
NCT04236414
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumours
Start date
2020-01-14
Primary completion
2025-02-04
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.